Vaccine Weekly articles from December 2004

Vaccine Weekly archives from December 2004

Mutations in dengue virus vaccine candidate decreases virus replication.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining...

Recent developments in prion immunotherapy reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers review recent developments in prion immunotherapy in the journal Current Opinion in Immunology. According to a study from Switzerland, "Antibody-based immunotherapy may represent a...

Immunodominant sites on spike protein of SARS coronavirus identified.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists have identified immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus. "The spike (S) protein of severe acute respiratory syndrome (SARS)...

Myopericarditis reported following smallpox vaccination.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The incidence of myopericarditis following smallpox vaccination was higher than expected. "Myopericarditis has been a rare or unrecognized event after smallpox vaccinations with the New York City...

Prime-boost strategy developed using Salmonella enterica Typhi.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed a prime-boost strategy using recombinant Salmonella enterica serovar Typhi. According to recent research from the United States, "This study investigated the utility of...

AIDS protection dependent on persistence of vaccine virus.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus. According to published research from the...

Avoiding deceptive imprinting in AIDS vaccine development reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists outline methods to avoid deceptive imprinting of the immune response to HIV-1 infection in vaccine development in a recent issue of International Reviews of Immunology. According to a...

HIV-1 Tat protein modulates generation of cytotoxic T cell epitopes.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity. According to a study from Italy, "Tat, the trans activation...

HIV-1 Tat vaccine protects against SHIV89.6P replication in monkeys.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- HIV-1 Tat vaccinated cynomolgus monkeys were protected against SHIV89.6P replication. According to a study from Italy, "Vaccination with a biologically active Tat protein or tat DNA contained...

HIV-1 gp120 and immune network reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers review HIV-1 gp120 and the immune network in a recent issue of International Reviews of Immunology. According to a study from Yugoslavia and the United Kingdom, "It has been...

Inflammatory stimuli increase neutrophil binding of HIV.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Activation by inflammatory stimuli increases neutrophil binding of human immunodeficiency virus type 1 and subsequent infection of lymphocytes. According to recent research from the United States,...

Pseudoviruses encoding gag induces HIV gag-specific mucosal immunity.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Oral immunization with papillomavirus pseudoviruses encoding gag induced HIV-1 gag-specific mucosal immunity. "Mucosal surfaces are the primary portals for human immunodeficiency virus (HIV)...

Recombination property of HIV-1 gp120 gene reported.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers report the recombination properties of the HIV-1 gp120 gene in a recent issue of International Reviews of Immunology. According to a study from Yugoslavia, "Using a chimeric primer...

Retroviral vectors used to analyze SIV/HIV-specific T cell responses.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have used retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses. "CD8+ T cell responses and particularly cytotoxic T lymphocyte (CTL) activity are critical...

nef-deleted SHIV protects against pathogenic virus infection.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A nef-deleted simian and human immunodeficiency virus (SHIV) protected against pathogenic virus infection. According to published research from Japan, "To clarify the involvement of primitive...

Beta-sheet breaker peptide prevents Alzheimer's memory impairments.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A beta-sheet breaker peptide prevents A-beta-induced spatial memory impairments with partial reduction of amyloid deposits. "Current evidence supports the notion that beta-amyloid deposits or...

Complications of Alzheimer vaccination in nonhuman primates modeled.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists have modeled hemorrhagic and encephalitic complications of Alzheimer amyloid-beta vaccination in nonhuman primates. "The potential of amyloid-beta (A-beta) immunization as a...

Neuroscientists awarded $1.1 million grant to improve Alzheimer vaccine.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- University of South Florida (USF) College of Medicine neuroscientists have been awarded a $1.1 million federal grant to improve the safety and effectiveness of an Alzheimer vaccine in a mouse model. ...

Company gets $877.5 million U.S. government contract to supply anthrax vaccine.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc. (VXGN) announced that the U.S. government has awarded the company an $877.5 million contract to supply 75 million doses of anthrax vaccine for civilian defense. The contract, the first...

Plasmid DNA vaccine protects against aerosolized anthrax spores.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores. According to a study from the United States, "DNA vaccines provide...

Vaccine protects cheetah and black rhinoceros against anthrax.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have developed a vaccine that protects cheetahs and rhinoceroses against anthrax. According to a study from England, Namibia, and the United States, "Institution of a policy of...

Virus-induced auto-antibody responses characterized.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists have characterized virus-induced auto-antibody responses. "Here we present a comprehensive molecular mapping of virus-induced autoimmune B cell responses obtained by serological...

Investigators awarded grants from U.S. DoD Breast Cancer Research Program.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Five scientific investigators at The Scripps Research Institute were awarded research grants from the U.S. Department of Defense (DoD) Breast Cancer Research Program. The following awards were made...

Immunotherapeutics company sees Q3 revenue increase.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Corixa Corp. (CRXA), a developer of immunotherapeutics, announced financial results for the third quarter ended September 30, 2004. For the third quarter of 2004 Corixa reported total revenue of...

Pharma company reports third quarter 2004 results.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Point Therapeutics, Inc., (NASDAQ: POTP) reported results for the fiscal quarter and 9 months ended September 30, 2004. During the third quarter of 2004, Point achieved the following key...

Antibodies redirect cytolytic capacity of cytotoxic T lymphocytes.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- RGD-modified anti-CD3 antibodies redirect cytolytic capacity of cytotoxic T lymphocytes toward alpha[subscript]vbeta[subscript]3-expressing endothelial cells. "To redirect the lytic activity of...

Cancer vaccines must break immune tolerance to malignant cells.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Cancer vaccine development involves breaking immune tolerance to malignant cells. "Exploiting a naturally occurring defense system, the immunotherapeutic approach embodies an ideal nontoxic...

IL-6 regulates dendritic cell differentiation through STAT3 activation.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. "Dendritic cells (DCs) orchestrate immune responses according to their state of maturation. In response to infection,...

Lipid-core-peptides increase adjuvant activity of T cell peptides.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Incorporation into lipid-core-peptides increased the adjuvant activity of minimal CD8 T cell peptides. "A problem facing the use of subunit peptide and protein vaccines is their inability to...

Melanoma vaccination results presented at conference.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Generex Biotechnology Corporation (NASDAQ:GNBT) announced the presentation by Nikoletta Kallinteris, the Antigen Express Project Leader, Ii-Key Hybrid Technology, who preformed these studies, at the...

PHB1/PHB2 identified as blood-borne tumor antigens.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Differential immunization has identified PHB1/PHB2 as blood-borne tumor antigens. "Early diagnosis of cancer is crucial for successful treatment. Noninvasive assays for detecting tumor-derived...

Susceptibility of tumors to immunotherapy changes during maturation.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The susceptibility of tumors to innate and adaptive immunotherapy changes during tumor maturation. "Immunotherapy of tumors using T cells expanded in vitro has met with mixed clinical success...

DNA vaccine protects against lethal canine distemper virus challenge.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Immunization with plasmid DNA encoding the hemagglutinin and the nucleoprotein confers robust protection against a lethal canine distemper virus challenge. According to recent research from Denmark...

HPV vaccine shown to "substantially" reduce cervical cancer.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- An international clinical trial has shown extremely promising results for a vaccine against the most common causes of cervical cancer. Diane Harper of the Norris Cotton Cancer Center at...

Company details clinical development plan for CG53135 and CR002.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- CuraGen Corp. (CRGN) announced progress with their pipeline of protein, antibody, and small-molecule therapeutics highlighted by the transitioning of CG53135 into phase II for the prevention of oral...

Studies in male monkeys demonstrate that immunocontraception could work.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Experiments designed in North Carolina and conducted in India with macaque monkeys show for the first time that it should be possible to create a safe, effective, and readily reversible form of...

Research institute announces discovery on the virus' role in autoimmune disease.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers at the La Jolla Institute for Allergy & Immunology announced the addition of a milestone to scientific understanding of the role viruses play in the development of autoimmune diseases, such...

Data show FG-3019 improves kidney function in late-stage disease model.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- FibroGen, Inc., announced that FG-3019, the company's lead investigational antifibrotic agent, significantly improved glomerular filtration rate (a measure of kidney function) and reduced proteinuria...

Whole blood cytokine detection assay to quantitate T-cells developed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists have developed a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. According to recent research from the United States and South...

Treatment of diarrhea and dysentery in Thailand described.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Treatment of diarrhea and dysentery in Kaengkhoi district, Saraburi province, Thailand is described. "To estimate the proportion of cases missed in a passive surveillance study of diarrhea and...

Persistent itching nodules caused by diphtheria-tetanus toxoid vaccines.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers report persistent itching nodules after the fourth dose of diphtheria-tetanus toxoid vaccines without evidence of delayed hypersensitivity to aluminum. "Studies in Gothenburg, Sweden,...

Cultural context of dysentery has implications for vaccine introduction.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The cultural and social contexts of dysentery have implications for the introduction of a new vaccine. "Dysentery, a severe form of diarrheal disease, is a major cause of morbidity and mortality....

Formaldehyde-inactivated Japanese encephalitis virus vaccine developed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A formaldehyde-inactivated Indian strain of Japanese encephalitis virus grown in Vero cells "P20778, an Indian strain of Japanese encephalitis virus (JEV) obtained from Vellore in the Southern...

Autoimmune encephalomyelitis cured by Trypanosoma cruzi infection.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Experimental autoimmune encephalomyelitis can be prevented and cured by infection with Trypanosoma cruzi. "Trypanosoma cruzi is an intracellular parasite that induces a strong Th1-type response and...

Epstein-Barr virus antigen elicits anti-dsDNA and anti-Sm antibodies.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. According to published research from the United States,...

Repeated boosting with E. coli bacterin needed for high antibody levels.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Repeated boosting with J5 E. coli bacterin is required to generate high levels of cross-reactive IgG[subscript]2 antibodies. According to published research from the United States,...

Biophharmaceutical company reports cash position, net cash expenditures for Q3.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Transgene (TRGNY) announced cash position and net cash expenditures for the third quarter and the 9 months ended September 30, 2004 (unaudited figures, USGAAP). Net cash expenditures amounted to EUR...

Drug developer of upper respiratory therapies reports third quarter financials.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- SinoFresh HealthCare, Inc. (SFSH), producer of an over-the-counter antiseptic nasal spray to treat chronic sinus conditions, announced financial results for the third quarter ended September 30, 2004....

Genetics-based company reports third quarter 2004 financial results.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corporation (TGEN) announced its financial results for the third quarter of 2004. Revenue for the third quarter of 2004 was $2.4 million compared to $5.0 million for the third...

TNFerade maker reports increase in revenues, dip in losses during Q3.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- GenVec, Inc., (GNVC), announced financial results for the third quarter and 9 months ended September 30, 2004. GenVec reported higher revenues and a lower net loss for the third quarter and first 9...

Biotechnology company submits re-examiniation request for Benitec.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Nucleonics, Inc., announced that it has filed with the Commissioner of Patents in Australia a request for re-examination of Benitec and Commonwealth Scientific and Industrial Research Organization's...

Infectech, Inc., reports validation of mycobacteria avium complex kit.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Nutra Pharma Corp., (OTCBB: NPHC) Infectech, Inc. (Pink Sheets: IFEC) has received further verification of its technology by Dr. Paul Hyman of Ohio State University. Hyman has achieved the...

New information on TRIZIVIR presented at conference.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- GlaxoSmithKline (GSK) announced that new information from ongoing clinical trials investigating varied clinical applications for TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) were presented at...

Pharma company files application with FDA for antiretroviral agent.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Ranbaxy Inc., a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), announced that RLL had filed an ANDA with the U.S. Food and Drug Administration (FDA) for Zidovudine Tablets, 300 mg. ...

Phase II data for HIV drug presented at conference.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Ono Pharmaceutical Co., Ltd., announced that a phase II clinical study with a new HIV drug (development code: ONO-4128/873140) has been completed. The results of the study were presented at the 44th...

Phase IIa study show Reverset potentially reduces HIV viral load.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Incyte Corporation (Nasdaq:INCY) announced that patients with HIV who were failing antiretroviral therapy showed a reduction in viral load following treatment with Reverset, a nucleoside-analogue...

VScan HIV test kits are being shipped to Japan.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Medical Services International Inc. (Pinksheets: MSITF) announced that it has begun to ship the VScan HIV rapid test kit to Japan. The company now ships the VScan HIV test kits to six different...

Indian firm withdraws its HIV drugs from World Health Organization list.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- India's Ranbaxy Laboratories is withdrawing all of its generic versions of antiretroviral drugs from the World Health Organization (WHO)'s list of approved HIV medicines, saying it is uncertain they are...

Molecular makeup of HIV-1 envelope protein described.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Scientists describe the molecular makeup of the HIV-1 envelope protein in a recent issue of International Reviews of Immunology. According to recent research from Yugoslavia, "A broad range of...

State of the art in AIDS vaccines reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers review the state of the art in AIDS vaccines in a recent issue of International Reviews of Immunology. According to a study from Yugoslavia, "This overview briefly summarizes the...

VIP/NTM-reactive natural antibodies applied to HIV infection therapy.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have applied VIP/NTM-reactive natural antibodies to HIV infection therapy. "In sera of HIV-infected individuals natural antibodies recognizing nonimmunogenic C-terminal domain of the...

Trial results for spi-VECTM oral immunotherapeutic vaccine reported.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Microscience announced further significant results from a phase I clinical study of its spi-VECTM oral immunotherapeutic vaccine designed for the treatment of subjects chronically infected with the...

Britain should adopt universal hepatitis B immunization, says doctor.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Britain should adopt universal hepatitis B immunization, says a senior doctor. The United Kingdom is one of the few developed countries that have not implemented universal immunization. Because the...

European authorities give positive opinion for Fendrix vaccine.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Further to the filing for regulatory approval with the European Agency for the Evaluation of Medicinal Products (EMEA) in May 2003, GlaxoSmithKline Biologicals (GSK Bio) has received a positive opinion...

Outbreak of hepatitis B in drug users causes high mortality.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- An outbreak of acute hepatitis B among injection drug users caused fulminant liver failure resulting in high mortality. "Death related to acute hepatitis B occurs in approximately 1% of patients....

Phase II trial data announced on new HBV vaccine.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Dynavax Technologies (DVAX) announced that data from a randomized, double-blind, phase II, clinical trial of the company's prophylactic hepatitis B virus (HBV) vaccine showed superior results compared...

Aggresome-like structures form in herpes virus type 2-infected cells.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Aggresome-like structures form in herpes simplex virus type 2-infected cells, which play a potential role in virus assembly. According to a study from Japan, "Herpes simplex virus (HSV) is a large,...

Tests for antibodies against bovine herpesvirus 1 evaluated.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers have evaluated tests for antibodies against bovine herpesvirus 1 performed in national reference laboratories in Europe. "Sets of serum and milk samples were collected from various...

In vivo function of gamma-herpesvirus virion glycoprotein described.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers describe the in vivo function of gamma-herpesvirus virion glycoprotein in a recent issue of the Journal of Virology. According to a study from the United Kingdom, "The human...

Structure of anti-human immunodeficiency virus type 1 antibody 2F5 reported.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Researchers report results of a structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope in a recent issue of the Journal of...

Comprehensive screening detects new epitopes in hepatitis C virus NS3 antigen.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Comprehensive screening detects new epitopes in hepatitis C virus NS3 antigen. "Interferon-gamma (IFN-gamma)-producing CD8+ T cells have been shown to play a key role in the control or eradication...

Financial challenges of immunization reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Investigators review the financial challenges of immunization programs in a recent issue of the Bulletin of the World Health Organization. "Securing reliable and adequate public funding for...

Marginal zone B cells deposit immune complexes onto dendritic cells.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. According to published research from the United States, "Secreted IgM and complement are...

Oral mucosal immunology reviewed.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- A scientist reviews oral mucosal immunology in a recent issue of the Annals of the Academy of Medicine Singapore. "The primary function of the immune system of the mouth is to protect the teeth,...

Research institute announces $12 million in NIH contracts for smallpox research.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The La Jolla Institute for Allergy and Immunology announced that it received contracts totaling nearly $12 million from the National Institute of Allergy and Infectious Diseases (NIAID), part of the...

Study compares hepatitis B treatments.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Bristol-Myers Squibb announced that data from two studies show its investigational chronic hepatitis B compound, entecavir, demonstrated significantly greater improvements in both liver histology and...

340,000 doses of influenza vaccine to be distributed in Pennsylvania.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Health Secretary Dr. Calvin B. Johnson announced that the U.S. Department of Health will distribute about 340,000 doses of influenza vaccine that the U.S. Centers for Disease Control and Prevention...

CDC and states announce plan to distribute 10.3 million flu shots nationwide.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Working closely with public health officials nationwide, the U.S. Centers for Disease Control and Prevention (CDC) announced plans to distribute the remaining 10.3 million doses of Aventis Pasteur...

CDC to include FluMist in vaccines for children program.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced that FluMist (Influenza Virus Vaccine Live, Intranasal) has been included in the federal government's Vaccines for Children (VFC) program as an alternative to the...

Computerized orders increase administration of influenza, pneumococcal vaccines.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Computer-based standing orders are more effective than computerized reminders to physicians in increasing influenza and pneumococcal vaccine administration for hospitalized patients, according to a new...

Flu preparedness must become public health priority.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- Influenza experts at a Pan American Health Organization technical meeting said that national preparedness plans to confront a potential influenza pandemic must become a "public health priority without...

15,000 people request a flu shot in Arizona county vaccine lottery.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The Maricopa County, Arizona, Department of Health has received some 15,000 requests from residents for flu shots in a vaccine lottery. The county received about 5,000 more entries the day after the...

Additional doses of flu vaccine available for at-risk people in Louisiana.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- The Louisiana health department has received additional doses of flu vaccine for distribution to parish health units. Roughly 50,000 doses will be available. They are being distributed to parish...

Alaskan health officials begin distributing more flu vaccine.
December 1, 2004... 2004 DEC 1 - (NewsRx.com & NewsRx.net) -- State health officials in Alaska have begun to distribute thousands of additional doses of influenza vaccine. But even with the additional doses, the state remains short of what was ordered to...